Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03827044
Brief Title: Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer (POLEM)

First Submitted : July 26, 2018
First Submitted that Met QC Criteria : January 30, 2019
First Posted : February 1, 2019

Last Update Submitted that Met QC Criteria : February 1, 2019
Last Update Posted : February 5, 2019